Our Approach
Item of Christian’s private collection of historic artefacts centering around the ritualistic use of psychedelics.
Dionysus is the god of the grape-harvest, winemaking and wine, insanity, ritual madness, religious ecstasy and the theatre.
It is important to understand in this context that the wine of the ancient Egyptian, Greek and Roman times cannot be compared with our today’s wine. It was often spiked – especially in religious context - with psychedelic substances – especially magic mushrooms and ergot.
We currently manage more than US$ 2.5 billion across seven strategies.
Four of them - Presight Capital, Apeiron Partners, Elevat3 and re.Mind Capital - are open for institutional investors via closed-end venture funds.
All of our investment teams deploy an extreme value-add and hands-on approach, aiming to be an entrepreneurial, reliable and long-term partner to our portfolio companies, and in the case of Apeiron Partners, to our portfolio funds.
Our core belief is that every company, at any given moment in its development, has between one and three “triggers”, which - if executed successfully - will immediately bring the company to the next valuation level. We focus on companies where we believe we can influence or control these triggers and create value for all stakeholders.
Our
Strategies
Platform Companies (internal capital only)
When we see major trends and structural changes happening in one of our core sectors, we set up and invest in platform companies/roll-up models to make concentrated and focused bets and acquisitions.
These platform companies offer centralized services and leadership – especially business development – and make most sense sectors where founders and innovators are often amazing innovators but lack the commercial or entrepreneurial skillset.
We have raised more than US$ 1 billion outside money in recent years for our various platform companies.
A few selected platform companies:
Co-CEO, Rejuveron Life Sciences, and Venture Partner, Apeiron Investment Group
Group CEO
Consultant, Special Situations
Apeiron Investment Group
Listed Equities & SPACs (internal capital only)
We take active minority stakes in listed companies mainly through IPOs & SPACs, but sometimes also later in a company’s life cycle.
We offer our listed companies the same attention and value-add as we give our venture portfolio.
Primarily, we initiate and sponsor our own SPACs – often together with strategic partners – focusing on certain high growth industries and/or regions.
Additionally, we invest in the SPACs of other sponsors, offering an entrepreneurial, long-term investor & partner who not only provides capital, but deal flow too.
A few selected portfolio companies:
Head of Public Markets Investments & Co-Head ECM
Apeiron Investment Group Ltd
Consultant, Special Situations
Apeiron Investment Group
ELEVAT3 - Lead Venture Deals in Europe
Elevat3 Capital is Apeiron's Germany-focused venture capital arm.
Elevat3 invests in European companies, with Peter Thiel's Founders Fund as a strategic partner. Elevat3's focus is on Germany, stage- and sector-agnostic, but concentrating on the key Apeiron sectors.
With Elevat3, we fully deploy Apeiron's "extreme hands-on" approach.
Co-Founder and General Partner
Co-Founder and General Partner
Co-Founder and General Partner
Presight Capital - Apeiron's flagship venture capital fund
We co-invest with top-tier VCs through Presight Capital - Apeiron's flagship venture capital fund.
Presight has invested in more than 60 companies alongside leading funds and investors such as Thiel Capital, Valar Ventures, Founders Fund, Orbimed, 8VC, Khosla Ventures, Holtzbrinck Ventures, Charles River Ventures, Amgen, SoftBank, Travis Kalanick, Elon Musk, Cherry Ventures, Project A, Third Prime, DCVC Bio, Tuesday Capital, Viking, Felix Capital, 468 Capital, Clocktower Ventures, Bill Gates, and Gigafund.
Co-Founder and General Partner
Co-Founder and General Partner
Apeiron Partners - Investments In Venture Funds
To complement and diversify our portfolio, we invest globally in venture capital funds via our Fund-of-Funds Apeiron Partners.
We invest in access-constrained, remarkable fund managers who have a high conviction approach and bold thesis for the future. Our core focus is emerging early-stage venture funds, but we also construct selected positions in top performing established funds.
Co-Founder and General Partner
Head of Investments
re.Mind Capital - Mental Health Venture Investments
re.Mind is a venture capital fund dedicated to the brain and mind.
It is the largest venture fund globally solely dedicated to investing into mental and neurological health.
Our focus areas include brain-computer interfaces, personalization, new pharmacology, new modalities, and more.
Co-Founder and General Partner
Co-Founder and General Partner
Co-Founder and General Partner
LIMESTONE CAPITAL - Fully Integrated Hospitality Investments
Limestone Capital is a fully integrated investment firm focused on the hospitality sector.
Limestone utilizes a highly selective investment approach focused on high quality, differentiated assets with attractive risk-adjusted returns. The firm focuses on destinations within the EU where it sources, develops and operates unique properties requiring significant repositioning, management change and quality design.
Founder
Aethos
Co-Founder
Aethos Hotels
Co-Founder and General Partner
General Partner